Contractors received correspondence from SPPG on 23rd January 2024 as follow-up to previous SPPG and CPNI correspondence.
The SPPG correspondence outlines that there is no facility for BSO to provide retrospective modelling information to individual contractors in relation to planned NIDT clawback changes. This is disappointing and unfortunately limits your ability to understand the potential implications of the planned clawback changes on your BSO payments.
The reality of either the previous or planned new clawback models is that the NIDT arrangements differ significantly from the Scottish clawback arrangements where generic clawback remains at 0%, with branded clawback reduced on all qualifying medicines to 1.79% from December 2023. A consequence of applying either the previous NIDT or the planned new NIDT clawback arrangements is that they will contribute to the on-going and worsening financial environment that contractors are operating in.
CPNI continues to make representations to senior DoH(NI) and SPPG officials in relation to a range of financial, workload and workforce issues that contractors are experiencing.
A contractor meeting will be held, in-person, w/c 5th February 2024 at which further information on funding, clawback, services and other issues will be provided to you.
Further details associated with the contractor meeting will be provided in due course.
Please do not hesitate to contact CPNI offices should you require any additional information.
Yours sincerely
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
You will be aware that The Pharmaceutical Society of Northern Ireland (PSNI) issued correspondence to registrants on 20 July 2023 with regard to meeting regulatory standards during periods of global and national shortage of medicines. CPNI issued a Contractor Update on 21 July 2023.
PSNI again wrote to pharmacists on 17 January 2024 (here) indicating that some of the resources mentioned in the earlier statement have been updated.
Note that the advice issued in the original statement concerning meeting relevant regulatory standards still stands, including that underscoring the importance of professionals being able to account for their decisions.
Contractors should contact PSNI or their local SPPG office in the first instance should further information be required. CPNI colleagues are also available for assistance.
Kind regards
Mike
SENT ON BEHALF OF PROF MIKE MAWHINNEY Head of Regulatory Affairs
This update contains important information for community pharmacy teams.
Correspondence regarding the Living Well service has been issued by SPPG 19th January 2024 and can be accessed here.
SUMMARY
SPPG and PHA have issued an invite to community pharmacists that provide the Living Well service to participate in a focus group.
The focus group will give community pharmacists an opportunity to discuss what works well, what challenges are experienced, and to give suggestions for potential improvement to the service.
ACTION
Contractors who provide the Living Well Service should read the correspondence issued by SPPG 19th January 2024.
Those pharmacists who wish to be involved in the focus group should confirm their attendance by completing the Microsoft Form provided by SPPG by 31st January 2024.
Please share this information with all relevant team members.
For any queries in relation to the Living Well Community Pharmacy service, please contact Pharmacy Adviser, katie.blair@hscni.net.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
